Company page

Meiragtx Holdings Plc

Meiragtx Holdings Plc, trading under the ticker MGTX, is a public company based in the United States with a market capitalization of approximately $1.05 billion. The company is focused on developing innovative gene therapies to address serious diseases. Meiragtx is committed to advancing its research and development efforts to bring new treatment options to patients.